Paratek Pharmaceuticals, Inc. (Inactive) (extinct)

Paratek Pharmaceuticals, Inc. (Inactive) (extinct)

Paratek Pharmaceuticals, Inc. (Inactive) (extinct)

Overview
Date Founded

1996

Headquarters

75 Kneeland Street,Boston, MA 02111

Type of Company

Private

Industries

Pharmaceuticals
Retail: Drug Stores

Company Description

Paratek Pharmaceuticals, Inc. operates as a pharmaceutical company that focuses on the discovery, development, and commercialization of medicines. The firm’s lead product candidate, omadacycline, is a new tetracycline-derived, broad-spectrum antibiotic being developed for use as a first-line monotherapy for serious community-acquired bacterial infections where antibiotic resistance is of concern for treating physicians. The company was founded by Stuart B. Levy and Walter A. Gilbert on July 3, 1996 and is headquartered in Boston, MA.

Contact Data
Trying to get in touch with decision makers at Paratek Pharmaceuticals, Inc. (Inactive)? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Outside Counsel

Paths to Paratek Pharmaceuticals, Inc. (Inactive)
Potential Connections via
Relationship Science
You
Paratek Pharmaceuticals, Inc. (Inactive)
Recent Transactions
Details Hidden

purchases Paratek Pharmaceuticals, Inc. (Inactive) from Aisling Capital, Omega Funds, HBM Healthcare Investments AG

Details Hidden

Paratek Pharmaceuticals, Inc. (Inactive) raised money in a private placement transaction

Transaction Advisors
Investment Advisor

Advised onParatek Pharmaceuticals, Inc. (Inactive) raised money in a private placement transaction

Legal Advisor

Advised on purchases Paratek Pharmaceuticals, Inc. (Inactive) from Aisling Capital, Omega Funds, HBM Healthcare Investments AG

Legal Advisor

Advised on purchases Paratek Pharmaceuticals, Inc. (Inactive) from Aisling Capital, Omega Funds, HBM Healthcare Investments AG

Legal Advisor

Advised on purchases Paratek Pharmaceuticals, Inc. (Inactive) from Aisling Capital, Omega Funds, HBM Healthcare Investments AG

Head, Private Equity Practice

Advised on purchases Paratek Pharmaceuticals, Inc. (Inactive) from Aisling Capital, Omega Funds, HBM Healthcare Investments AG

Legal Advisor

Advised on purchases Paratek Pharmaceuticals, Inc. (Inactive) from Aisling Capital, Omega Funds, HBM Healthcare Investments AG

Investors
Details Hidden

Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC provides legal services and resources. The company offers services to the communications, education, environmental, health, immigration, public finance, real estate and tax industries. It was founded in 1933 and is headquartered in Boston, MA.

Details Hidden

Phase4 Partners invests in life science and biopharmaceutical companies with high quality science and strong intellectual property. The firm provides financing for mid to late stage capital requirements with an investment size of $15 to $30 million. The firm also makes follow on investments.

Details Hidden

OFM is a private equity investment manager focused on secondary investments in the healthcare sector. The firm acquires stakes in public and private companies which are active in fields related to biopharmaceuticals and medical devices. They invest globally, focusing on Western Europe and North America. They acquire direct equity interests or portfolios of participations from a variety of investors, ranging from company founders to corporations and venture capital firms.OFM typically takes over equity interests in mature companies from early-stage investors looking for liquidity in their healthcare portfolio, as healthcare companies generally have long product development cycles with high capital demand.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Paratek Pharmaceuticals, Inc. (Inactive). The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Paratek Pharmaceuticals, Inc. (Inactive)'s profile does not indicate a business or promotional relationship of any kind between RelSci and Paratek Pharmaceuticals, Inc. (Inactive).